MAYNE PHARMA FDA Approval ANDA 065054

ANDA 065054

MAYNE PHARMA

FDA Drug Application

Application #065054

Application Sponsors

ANDA 065054MAYNE PHARMA

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL100MG/ML0CYCLOSPORINECYCLOSPORINE

FDA Submissions

ORIG1AP2001-12-18
LABELING; LabelingSUPPL2AP2002-05-03
LABELING; LabelingSUPPL3AP2004-05-14
LABELING; LabelingSUPPL4AP2004-12-02
LABELING; LabelingSUPPL8AP2007-02-05
LABELING; LabelingSUPPL10AP2007-11-16
LABELING; LabelingSUPPL19AP2015-01-20STANDARD

Submissions Property Types

SUPPL19Null15

TE Codes

001PrescriptionAB1

CDER Filings

MAYNE PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 65054
            [companyName] => MAYNE PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"CYCLOSPORINE","activeIngredients":"CYCLOSPORINE","strength":"100MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CYCLOSPORINE","submission":"CYCLOSPORINE","actionType":"100MG\/ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.